chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Nasal Swab: Positive; Nasal Swab: Positive; blood clots; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the parent.  A 20 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administration date May2021 (Batch/Lot number: unknown) at the age of 20 years as dose 2, single and (Batch/Lot number: unknown) as dose 1, single for covid-19 immunization. The patient had no relevant medical history. The patient's concomitant medications were not reported.The following information was reported: COVID-19 (hospitalization, disability, medically significant, life threatening), DRUG INEFFECTIVE (hospitalization, disability, medically significant, life threatening) all with onset 04Feb2022, outcome "not recovered" and all described as "Nasal Swab: Positive"; THROMBOSIS (hospitalization, disability, life threatening) with onset 02Jun2021, outcome "not recovered", described as "blood clots". The patient was hospitalized for covid-19, drug ineffective, thrombosis (hospitalization duration: 2 day(s)). The event "blood clots" was evaluated at the physician office visit and emergency room visit. The patient underwent the following laboratory tests and procedures: blood test: (unspecified date) none, notes: single blood test and none can come up; sars-cov-2 test: (04Feb2022) positive, notes: Nasal Swab. Therapeutic measures were taken as a result of thrombosis.  Clinical Course: Patient was prescribed with Eliquis and was hospitalized for 2 days. She did not receive other vaccine in four weeks. she did not test COVID positive prior vaccination but COVID tested positive post vaccination  The lot number for [BNT162B2], was not provided and will be requested during follow up.
Hallucination, on 06/09/2017, Recurrent palpitation (tachycardia) on/off since the day of the vaccination. She has been to the Emergency Room since then and EKG was normal. She only reported the event to me today, she has been evaluated, all was normal. She has been referred to a pediatric cardiologist for further evaluation and meantime blood has been drawn for thyroid function tests.
Reports fever, chills, headache, nausea, cough, sore throat, runny nose starting 2/10, most lasting 24 hours. TM continues to experience sore throat
On 8/14/98 pt received one dose of varicella virus vaccine live. The pt was confirmed that she was pregnant (09/18/1998); the pt gave birth to a normal healthy male (04/17/1999)per follow-up. The baby experienced a fever of 99.4F. No further information is available.
Bounding heartbeat ranging 104-114 checked twice, at rest for extended period on day 1 and day 2  Weakness and dizziness
an unspecified patient "was choking" after receiving a dose of ROTATEQ on an unspecified date "about 2 months ago".; This spontaneous report was received from a physician, referring to a 2-months-old male patient. The patient had no concurrent conditions, concomitant medications, and previously drug reactions or allergies. The patient's medical history included a premature birth (reported as preemie) and myocele.   On an unspecified date in October 2019, reported as "about 2 months ago", the patient was vaccinated with Rotavirus Vaccine, Live, Oral, Pentavalent (ROTATEQ) orallly, as prophylaxis (strength, formulation, dose number, dose, frequency, lot number and expiration date were unknown by the reporter).  It was reported that, after the vaccination with rotavirus vaccine live, oral pentavalent (ROTATEQ), the patient started choking, however, it was reported that the patient recovered during the same office visit. There was no treatment given to the patient per the event, no laboratories or exams were performed to the patient, also it was reported that the event was not related to cancer or overdose, and that the patient did not seek medical attention.  At the time of this report, the causality assessment between the event choking and the vaccination with rotavirus vaccine live, oral pentavalent (ROTATEQ) was not provided.   Upon internal review, the event choking was considered to be medically significant.
Left arm swollen at inj. site & red yesterday. Slightly improved today, achy & vomiting today. Arm was painful yesterday, but improved today. Rx given for ZOFRAN & return if worse.
pt recv vax & the same day pt exp a rash on face, ear, & neck;
Woke up in middle of the night as felt wet on pillow- pillow soaked with blood which was bright red with clots covering a very large portion of my pillow. I got up and went to the bathroom- spit out atleast 3 large blood clots that were almost the size of ?? an apricot. The bleeding continued for 40 minutes. I applied pressure at the nostrils and bridge of nose. When it did not stop, applied a very cool compress to the nose and face while husband held pressure on the bridge of my nose. At 45 minute mark, the bleeding went to only light red when dabs my nose.
Patient came to received his Covid-19 shot.  After the shot, he was instructed to wait 15 minutes nearby for observation.  The patient was standing up reading the EUA given to him,  felt dizzy, and fell to the ground.  This happened approximately 5 minutes after the shot. He was able to get up by himself and sit down to a chair, where he requested water. He proceeded to vomited as he was sitting down.
1 day after administration of MMR vaccine, pt. developed diffuse macular rashes on her abdomen, which spread to her B/L thighs and legs as well as some lesions on both arms.  Pt. also developed a headache and abdominal discomfort.
Received the PREVNAR 13 and FLUZONE HIGH DOSE (NDC: 49281-0403-65) in left arm. Two days later my left arm by the shots was hard, swollen, hot and red. This continued for over 5 days. The redness and swelling migrated to the underside of the same arm. It is still red and hot today (9 days after vaccines). It is also itchy. Pharmacist recommended BENADRYL. This was taken over the weekend. I took 3 pills but they did nothing but make me sleepy and nauseous. I returned to the pharmacy and was told to try ZYRTEC. This did nothing. The nurse helpline suggested ice. My left shoulder and arm are also feel weaker and lifting causes muscle aches. My left hand has also been sore. This has affected my sleeping.
This spontaneous report was received from a nurse refers to multiple unspecified patients of unknown age and gender. On an unknown date, the patients were vaccinated with improperly stored doses of PEDVAXHIB (dose, frequency, route of administration and indication were not reported, lot number# J016187, expiration date: 21-OCT-2016, K002746, expiration date: 09-DEC-2016, K011077 expiration date: 30-MAR-2017). This is one of the several reports received from the same reporter. Additional information has been requested.
Client has history of multiple allergies, denies allergy to components of vaccine.  Moderna vaccine given at 10:50 am, client complains of numbness in right shoulder with tingling down to hand.  Client denies any shortness of breath, no difficulty swallowing, no chest tightness.  Vital signs stable through out observation.  Numbness and tingling lessened prior to discharge, client made aware to follow up with primary care provider for second dose guidance, ER precautions given.   Client leaves observation area with steady gait at 11:20 am.
redness, swelling & heat cover half of lt upper arm, sit eof inj; no bleeding, no d/c, no SOB; pt treated w/DPH & cold compresses;
sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm) in a female patient of an unknown age who received mRNA-1273.815 (SPIKEVAX 2023-2024) for COVID-19 prophylaxis.     No Medical History information was reported.    On 19-Sep-2023, the patient received dose of mRNA-1273.815 (SPIKEVAX 2023-2024) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (sore arm). At the time of the report, PAIN IN EXTREMITY (sore arm) had not resolved.        The action taken with mRNA-1273.815 (SPIKEVAX 2023-2024) (Unknown) was unknown.   For mRNA-1273.815 (SPIKEVAX 2023-2024) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was reported.  No treatment information was reported.   Reporter did not allow further contact
pt recv vax FEB97 & devel visual disturbance;20MAR97 pt was given dose 2 of vax;sx cont;
Client presented for first dose Moderna Covid Vaccination.  30 minutes after receiving vaccination rash developed in midriff area.  States this occurred a number of times with flu vaccine and was advised not to take that again.  Rash is very difficult to see.  It is very fine an very slightly pink, barely raised.  States itch is minor.  Historically the flu rash became very itchy and burned somewhat  After 30 more minutes rash had not worsened.  Client felt comfortable leaving, stating resources she would access if symptoms worsened.  BP 140/88.  Pulse 82. States she is under treatment for Hypertension.
COVID arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE REACTION (COVID arm) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025B21A) for COVID-19 vaccination.     Concomitant products included DULOXETINE HYDROCHLORIDE (CYMBALTA), ALPRAZOLAM (XANAX), IBUPROFEN, ATENOLOL, ALBUTEROL [SALBUTAMOL] and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for an unknown indication.    On 07-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE REACTION (COVID arm). At the time of the report, VACCINATION SITE REACTION (COVID arm) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       Treatment information was not provided by the reporter.   This case was linked to MOD-2021-289346 (Patient Link).
This spontaneous report as received from a licensed practical nurse refers to a patient of unknown age and unknown gender. The patient pertinent medical history was not reported. On 05-NOV-2013, the patient was vaccinated with ZOSTAVAX (dose strength and route was not reported) (lot # J006831 and expiry date: 14-SEP-2014) which was improperly stored. Primary reporter was reporting excursion of 6 F since 01-JUN-2013 (confirmed date) affecting ZOSTAVAX, nurse also reported that products were not stored in an overall average support range of -58 degree F and 5 degree F. No adverse effects reported. No product quality complaint (PQC) was reported for ZOSTAVAX. This is one of the several reports from the same reporter. Additional information has been requested.
3p received infection. 8:15 severe chills, vomiting until 2am. From 2am through the next day fever ( 100c) with it breaking through the night. Mild flu the next day with  general Malaise.  The chills were so intense that I was constricted for much of the time with little relieve. I would call them violent chills with a tetany kind of full body involvement.  Never have  I experienced chills like I have described. I?ve never had a reaction to vaccines and tend have a high tolerance. I did not contact my physician but spoke to colleagues who suggested  report the experience.
3/28/03 10 itchy papules that scabbed, associated altered mental status and seizures, varicella encephalitits and questionnable myasthenia gravis syndrome. CSF picture consistent with aseptic meningitis.
This prospective pregnancy case was reported by a healthcare professional and described the occurrence of injection site soreness in a 27-year-old female subject who was vaccinated with Flu vaccine (manufacturer unspecified), BOOSTRIX while pregnant. On 13 December 2010 the pregnant subject received a dose of Flu vaccine (unknown) as well as a 1st dose of BOOSTRIX at 0.5 ml in the left arm. On 12 January 2011 the pregnant subject inadvertently received a 2nd dose of 0.5 ml BOOSTRIX in the left arm. This was an extra dose of BOOSTRIX. The subject experienced vaccine exposure during pregnancy. On 12 January 2011, less than one day after vaccination with BOOSTRIX, the subject experienced injection site soreness (arm). At the time of reporting the events were unresolved. The healthcare professional considered that injection site soreness was probably related to vaccination with BOOSTRIX. The subject's date of last menstrual period and estimated date of delivery were not provided. The outcome of pregnancy was not known.
Patient presented to an offsite clinic on 08/12/2021. On this day Pfizer was given to the patient. This patient is out of age range for this specific vaccine. Then on 09/02/2021 The patient present to site to get the second dose of the Pfizer vaccine and the dose was given on 09/02/2021, the patient was also out of age range for the second dose as well. On 09/03/2021 the out of age range was noticed and this nurse called the patient and spoke to the parent/guardian. The parent/guardian was inform of the dose being given even though the patient was too young for the vaccine. The parent also stated that the patient has no underlying health condintions.
This spontaneous report was received from a healthcare worker (certified medical assistant) concerning a female patient of unknown age. On an unknown date in August 2007, the patient was vaccinated with the first dose of 0.5 milliliter (ml) of GARDASIL (lot number and expiry date unspecified), intramuscularly. On an unknown date in October 2007, the patient was vaccinated with the second dose of 0.5 ml of GARDASIL (lot number and expiry date unspecified), intramuscularly and would like to receive the third dose of GARDASIL at the time of report. Hence, the patient sought medical attention (clinic visit). No concomitant medications were reported. The patient had a physician but could not remember the name of her physician. No adverse effects were reported. Additional information is not expected.
On 1/9/21, patient reported to urgent care for lower back pain. Patient also reported chills, adenopathy, headache, and hypertension. Patient was given prescription of diclofenac and cyclobenzaprine. No further escalation of care.
Information has been received from a physician via the Poison Control Center concerning a 37 year old female with no history of allergic reactions and who was afebrile who on 02-NOV-2006 was vaccinated with her first ever vaccination of Pneumovax 23, 0.5 ml, IM. Concomitant medication was not reported. On 02-NOV-2006, the patient experienced swollen and taught left arm, injection site soreness, injection site warmth, injection site erythema, injection site swelling and injection site induration. Measurements of both arms for comparison were taken and the right arm was 27 cm and the left arm was 29 cm. The patient's heart rate was 70, respiratory rate was 20 and blood pressure measurement was 102/62. The physician reported that the patient was discharged to home and told to use warm compresses and was prescribed treatment with MEDROL dose pack. The patient was instructed to follow-up in the morning with her primary care physician. Additional information has been requested.
Information has been received from a consumer concerning her 13 year old daughter with scoliosis and underweight and with no drug allergies who on 08-JUN-2009 and 14-AUG-2009 was intramuscularly vaccinated with her first and second 0.5ml dose of GARDASIL respectively. There was no concomitant medication. 3 days later after the second dose, on 17-AUG-2009 the patient passed out and then started jerking for a few seconds. Afterwards she was very tired. She sat down for about 20 minutes and felt fine. The doctor did not believe that this was related to the vaccination. Unspecified medical attention was sought. No laboratory diagnostics studies were performed. The patient recovered on 17-AUG-2009. No further information is available.
Child present in office to receive flu vaccine only - sibling also being seen at same office encounter for 4 year well child visit.  Child apprehensive about receiving vaccinations and mother requested that child not be advised of vaccines until last possible moment to avoid causing additional anxiety.  Nurse attempted to verify child as the child receiving four total vaccines and then administered vaccines intended for 4 year old sibling to older child swiftly and then subsequently realized that vaccines injected in to incorrect child.  Mother advised of error and that report to be created.  Instructed to contact office immediately if child developed fever, redness or swelling at injection site, tenderness or worsening pain.  Mother appropriately concerned and expressed understanding.
My son complained of left arm pain, deltoid muscle soreness with both doses of the vaccine, which resolved in 3 days for both doses; My son complained of left arm pain, deltoid muscle soreness with both doses of the vaccine, which resolved in 3 days for both doses.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the parent.  A 11-year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 18Nov2021 13:00 (Lot number: Fk5618) at the age of 11 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "No" (unspecified if ongoing). The patient's concomitant medications were not reported. Past drug history included: No. The following information was reported: PAIN IN EXTREMITY (non-serious) with onset 2021, outcome "recovered" (2021), described as "My son complained of left arm pain, deltoid muscle soreness with both doses of the vaccine, which resolved in 3 days for both doses"; MYALGIA (non-serious) with onset 2021, outcome "recovered" (2021), described as "My son complained of left arm pain, deltoid muscle soreness with both doses of the vaccine, which resolved in 3 days for both doses.". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of pain in extremity, myalgia.  Additional information: The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient received no other medications within 2 weeks of vaccination. My son complained of left arm pain, deltoid muscle soreness with both doses of the vaccine, which resolved in 3 days for both doses. Only ibuprofen was given for comfort. The patient had no known allergies.   Follow-up: Follow-up attempts completed. No further information expected.
Patient received the third dose of Moderna on 10/30/2021 and experienced shaking, chills and fatigue that evening. On 11/1/2021 she had a sore left arm, swelling and redness. She reported a painful arm that is red and slightly itchy. She was seen in the office on 11/2/2021 for this. She developed a similar reaction to her second COVID-19 vaccine only this time it is much worse.
Injection site pain; This is a spontaneous report from a non-contactable consumer, the patient. A 36-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the arm left on 31Mar2021 at 13:00 (at the age of 36-year-old) as a single dose for COVID-19 immunisation. Patient did not have any medical history. The patient did not receive any medication within two weeks of vaccination. Patient did not report any allergy to food, medication and other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 31Mar2021 at 19:00, the patient experienced injection site pain. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the event. The clinical outcome of the event injection site pain was recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
I had petechia / Purpura on my lower legs, both and thought perhaps a rash, yet did not itch nor go away when  pressed my skin about  10 days after my Vaccine. I thought perhaps it was the new medication Spironolactone I began the 24 th, 3 days after the Pfizer Vaccine, yet My Dr did not believe so with the dose and never had seen. I stopped the Spironolactone  the 5th of April and had a biopsy the 9th and blood and urinalysis ..   Dr. stated my tests came back normal, and wanted me to go to my Primary care Dr.  and not resume Sprionoloctane MY primary Dr. recommended my not receiving the 2nd Covid vaccine dose I decided I would not anyhow  Note I had Covid 19 April 30 2020 I took upon myself May 22nd to retake Spironolactone and I have bee n on for over two weeks and zero reactions.. Concluding it was the vaccine which caused the Petechia as I have zero marks on my legs  I had a consult with My Primary Dr who informed me to contact you and make a  statement.  Apart from the above the moring after Vaccine I spriked a fever and was ill the following day. I also had extreme exhaustion , joint pain and my migraines have worsened to point I had to cut my work hours and I may lose my Health Insurance.  I am not recovered fully.. The petechia resolved in 2 weeks without the suggested steroid cream prescribed for me
Migranes followed by superficial thrombophlebitis of the right SSV, elevated red blood cell count
interchange of vaccine products; leg paralysis; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP), Program ID: (Unknown).  A female patient received BNT162b2 (BNT162B2 NOS), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation; elasomeran (COVID-19 VACCINE MODERNA), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Alzheimers" (unspecified if ongoing), notes: Yes,I placed her in a nursing home with Alzheimers approx. a month+ or - B4 pandemic hit. The patient's concomitant medications were not reported. The following information was reported: INTERCHANGE OF VACCINE PRODUCTS (disability, medically significant), outcome "unknown"; MONOPLEGIA (disability, medically significant), outcome "unknown", described as "leg paralysis".  Clinical course: I thank Pfizer, Moderna, etc. for the complete immunization of wife, (name-withheld), and my remaining lives. Yes, I placed her in a nursing home with Alzheimers approx. a month+ or - B4 pandemic hit, however, (name-withheld) does not deserve her leg paralysis & resulting wheel chair confinement following vaccination.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Swelling of leftside of lower lip occured approx. 15 min. after receiving Tdap vaccine. Pt. had already left clinic took 25 mg. of Benadryl at home. Returned to clinic. 1:15 pm with edema left lower lip. Cold compress applied on 5 min. off 5 min. Instructed if swelling increases to see ER or MD imnediately.